HERON THERAPEUTICS ($HRTX) posted quarterly earnings results for Q3 2026 on Monday, November 9th. The company reported earnings of -$0.03 per share, missing estimates of -$0.03 by $0.00. The company also reported revenue of $35,250,000, missing estimates of $38,250,000 by $-3,000,000.
You can see Quiver Quantitative's $HRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
HERON THERAPEUTICS Hedge Fund Activity
We have seen 69 institutional investors add shares of HERON THERAPEUTICS stock to their portfolio, and 69 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIMED ADVISORS LLC removed 9,816,940 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $4,189,869
- PALISADE CAPITAL MANAGEMENT, LP removed 6,326,113 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $2,699,985
- JW ASSET MANAGEMENT, LLC removed 3,610,210 shares (-96.2%) from their portfolio in Q3 2026, for an estimated $1,131,800
- MILLENNIUM MANAGEMENT LLC removed 3,560,426 shares (-46.7%) from their portfolio in Q2 2026, for an estimated $1,519,589
- D. E. SHAW & CO., INC. removed 2,884,205 shares (-96.0%) from their portfolio in Q2 2026, for an estimated $1,230,978
- MARSHALL WACE, LLP added 2,354,193 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,004,769
- NEW YORK STATE COMMON RETIREMENT FUND removed 1,882,551 shares (-73.1%) from their portfolio in Q2 2026, for an estimated $803,472
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.